Zoom company's video-conferencing service became so ubiquitous during the Covid-19 pandemic that its corporate name became a verb describing the act of firing up a video chat to connect with coworkers online. Zoom shares VIE:ZOOM rose seven-fold in 2020 as sales surged after millions of workers were stuck at home because of COVID-19 restrictions. By 2021,...
Moderna ( NASDAQ:MRNA ), the pioneering vaccine maker, reported a surprise fourth-quarter profit, sending ripples of optimism through the market. Bolstered by unexpected revenue and strategic cost-cutting measures, the company's resilience amid shifting tides in the pharmaceutical landscape has drawn both attention and applause. Unveiling the Numbers: Moderna's (...
Pfizer (NYSE:PFE) gained EU antitrust approval for its $43 billion acquisition of Seagen, a cancer drug maker. This acquisition, announced in March, is Pfizer's largest recent purchase, fueled by the financial success of its COVID-19 vaccines and treatments. The European Commission found no significant competition or pricing concerns in the 27-country European...
If you haven`t bought NVAX during the pandemic: Then you need to know that NVAX Novavax's recent achievements in gaining full marketing authorization for its COVID-19 vaccine, Nuvaxovid, in the UK and Singapore, alongside its availability in major U.S. pharmacies, have ignited optimism among investors. These milestones signify a bright future for NVAT...
Hi Guys, this is a Technical Analysis on BionTech (BNTX) on the 3 Day Timeframe. We are currently approaching a MAJOR RESISTANCE Trendline. This Trend started from the TOP in 08/2021. Everytime we've interacted with it in the past, we've been REJECTED. Will we get Rejected again? Well, we've had 3 touch points already. In trendline theory, it states that...
AstraZeneca's stock experienced a significant decline of over 4% on Monday due to uncertainties surrounding the future of CEO Pascal Soriot, as reported in the news. Initially, the company refrained from commenting on the report but later clarified that they do not engage in discussions regarding market rumors. Their shares, listed as NASDAQ: AZN, closed down...
BNTX (BioNTech) Healthcare sector German company. Produce the BioNTech biotechnology. Partnership with Pfizer. Nice long bottoming base since March. Triple bottom . It looks like a rectangle pattern . All moving averages turning up . A move above the blue zone (>195) could take it to 248 and maybe more. I'm long with a stop at 165. Trade safe!
Novavax Short Term - We look to Sell at 48.97 (stop at 53.42) Prices expected to stall near trend line resistance. Trading volume is increasing. The trend of lower highs is located at 55.90. Preferred trade is to sell into rallies. A break of yesterdays low would confirm bearish momentum. Our profit targets will be 22.96 and 13.90 Resistance: 50.00 /...
Market Analysis The 4 Kings are TOPGLOV, SUPERMX, KOSSAN & HARTA: (not to be confused with Andy Lau, Leon Lai, Aaron Kwok & Jacky Cheung) Fundamental good stocks with strong revenue and cash positions. However, those that chase these heavily promoted stocks at the high side would really need to hold long term in order to recoup. Not sure when it will happen...
Moderna Short Term - We look to Sell at 149.49 (stop at 160.31) Preferred trade is to sell into rallies. Closed below the 20-day EMA. Trades with a bearish descending triangle formation. Our overall sentiment remains bearish looking for lower levels. We look to set shorts in the early trade. Our profit targets will be 123.84 and 103.50 Resistance: 150.00...
ALERS EUROBIO SCIENTIFIC is a company on the French stock market in the vitro medical diagnostics and also producing CAVID19 tests. It made a nice CUP & Handle BO with volume EURONEXT:ALERS EURONEXT:ALERS ://www.tradingview.com/x/Uw1WlyDV/]https://www.tradingview.com/x/Uw1WlyDV/
Novavax - Short Term - We look to Buy at 83.80 (stop at 75.92) Price action has posted a bullish Engulfing Candle and is positive for short-term sentiment. We look for gains to be extended today. Short term oscillators have turned positive. Although the bears are in control, the stalling negative momentum indicates a turnaround is possible. Our profit targets...
Just a quick snapshot showing the 500% + price gain on crude oil from COVID crash in 2020 to March 2022. Over 500% increase. Given tensions in Ukraine and boycotts of Russia, this bull run is likely to continue.
This might be just a simple charting of the fall from grace for Pfizer (PFE), Moderna (MRNA) and BioNTech (BNTX). Compare the dates of dips with press coverage of fading covid19 efficiency and emerging adverse effects and the story becomes more complicated.
Always DYOR and understand the dynamics of these OTC stocks (known for pump & dump) but the fundamentals here are what will ultimately drive Sunshine Biopharma to return to it's formerly glorious highs but for now, it's relegated to the fractional levels that we see. On it's face, it looks like a no-brainer . . company shedding debt, increasing earnings (still no...
forming a nice wedge on longer timeframe. Price is coiling, but still below short term MA. Support at 33 and resistance at 43. Hard to expect strong ER next week on this chart. 33 is more likely than 43 in the short term.
Visiomed group - H4 - 25/01 next resistance to break 0.27, i think
I am quite sceptic about the official COVID-19 pandemic explanation given the fact that there had been a rehearsal of such pandemic on September 2019 called Event 201, which you can watch a recorded version of on Youtube . This event was held by WHO officials and major important sector actors. This has given a solid base to support the conspiracy thesis. I would...